|
№ |
Service Name |
Price, KZT |
|
1 |
Detection of human papillomavirus 16,18 by PCR |
3,000 |
|
2 |
DNA extraction from blood |
7,000 |
|
3 |
Analysis of EGFR gene mutations from DNA of tumor cells fixed in formalin and embedded in paraffin blocks (FFPE) by PCR |
200,000 |
|
4 |
Analysis of BRAF gene mutations from DNA of tumor cells fixed in formalin and embedded in paraffin blocks (FFPE) by PCR |
150,000 |
|
5 |
Analysis of KRAS gene mutations from DNA of tumor cells fixed in formalin and embedded in paraffin blocks (FFPE) by PCR |
175,000 |
|
6 |
Molecular genetic analysis of microsatellite instability (MSI) in DNA from paraffin blocks |
140,000 |
|
7 |
Molecular genetic analysis of BCR-ABL p210, marker for CML and AML |
26,000 |
|
8 |
Molecular genetic analysis of BCR-ABL p190, marker for CML and AML |
26,000 |
|
9 |
Molecular genetic analysis of BCR-ABL p230, marker for CML and AML |
26,000 |
|
10 |
Molecular genetic analysis of RUNX1/RUNX1T1 gene, marker for AML |
45,000 |
|
11 |
Molecular genetic analysis of inv(16) and t(16;16) CBFB/MYH11 gene, type A, D or E (e5e12, e5e8, or e5e7) |
45,000 |
|
12 |
Molecular genetic analysis of TEL/AML1 gene |
45,000 |
|
13 |
Molecular genetic analysis of FLT3 gene, oncogenic marker |
45,000 |
|
14 |
Quantitative determination of mutant allele V617F of JAK2 gene in genomic DNA from blood |
27,000 |
|
15 |
Quantitative determination of mutant alleles W515L and W515K of MPL gene in genomic DNA from blood |
46,000 |
|
16 |
Quantitative determination of mutant alleles insTTGTC and del52 of CALR gene in genomic DNA from blood |
46,000 |
|
17 |
Detection of mutations, chimeric transcripts, and copy number variants in 161 genes associated with tumor development, AmpliSeq for Illumina Comprehensive Panel |
450,000 |
|
18 |
Analysis of FGFR3 gene mutations and fusions from RNA of tumor cells fixed in formalin and embedded in paraffin blocks (FFPE) |
170,000 |
|
19 |
Standard karyotyping of bone marrow |
36,000 |
|
20 |
FISH method (ALL, CML, AML, CLL, MM, MDS) – 1 probe |
77,200 |
|
21 |
Immunophenotyping (one test) |
21,500 |
|
22 |
Screening for CLL and ALL |
150,000 |
|
23 |
T-cell acute lymphoblastic leukemia (T-ALL) |
185,000 |
|
24 |
T-cell chronic lymphoproliferative disorder (T-CLPD) |
166,000 |
|
25 |
Acute myeloid leukemia (AML) |
190,000 |
|
26 |
Stem cell determination |
39,500 |
|
27 |
Myeloma |
135,000 |
|
28 |
B-cell acute lymphoblastic leukemia (B-ALL) |
175,000 |
|
29 |
B-cell chronic lymphoproliferative disorder (B-CLPD) |
183,000 |